Blackstone Capital Partners V

Blackstone Capital Partners V (BCP V) is a $21.7 billion private equity fund managed by Blackstone that reached its final close in 2006. While the fund is a diversified investment vehicle, it is notable for its significant impact on the healthcare and life sciences sectors through several multi-billion dollar acquisitions. Key healthcare-related portfolio companies associated with this fund include Biomet, a global leader in orthopedic products, and Catalent, a premier provider of drug delivery technologies and manufacturing solutions for the pharmaceutical industry. The fund's strategy focused on large-scale buyouts of market-leading companies, providing the capital and operational expertise necessary to drive growth and strategic value before eventual exits through public offerings or mergers.